Inflammatory responses after endothelin B (ETB) receptor activation in human monocytes: New evidence for beneficial anti-inflammatory potency of ETB-receptor antagonism

Pulmonary Pharmacology and Therapeutics

Volumn 21, Issue 3, 2008, Pages 533-539

  Juergens, Uwe R ^a   Racké, Kurt ^b   Uen, Sakir ^a   Haag, Susanne ^b   Lamyel, Fathi ^b   Stöber, Meinolf ^a   Gillissen, Adrian ^c   Novak, Natalija ^a   Vetter, Hans ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c Robert Koch Klinik   (Germany)

Author keywords

Bosentan; Endothelin; Pulmonary arterial hypertension

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; BOSENTAN; ENDOTHELIN 1; ENDOTHELIN B RECEPTOR; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG INHIBITION; DRUG POTENCY; ENZYME METABOLISM; HUMAN; HUMAN CELL; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTI-INFLAMMATORY AGENTS; ANTIHYPERTENSIVE AGENTS; ARACHIDONATE 5-LIPOXYGENASE; ARACHIDONIC ACID; CELL LINE; CELL SEPARATION; DINOPROSTONE; FIBROBLASTS; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; LIPOXYGENASE INHIBITORS; MONOCYTES; RECEPTOR, ENDOTHELIN B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SULFONAMIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 43049128504     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2007.12.005     Document Type: Article

References (40)

1. Farber H.W., and Loscalzo J. Pulmonary arterial hypertension. N Engl J Med 351 (2004) 1655-1665
2. Mandegar M., Fung Y.C.B., Huang W., Remillard C.V., Rubin L.J., and Yuan J.X.J. Cellular and molecular mechanisms of pulmonary vascular remodelling: role in the development of pulmonary hypertension. Microvasc Res 68 (2004) 75-103
3. Clozel M., and Rubin L.J. The endothelin system in cardiopulmonary diseases (2004), Friedrich ReinhardtVerlag, Basel, Switzerland
4. Adner M., Geary G.G., and Edvinsson L. Appearance of contractile endothelin-B receptors in rat mesenteric arterial segments following organ culture. Acta Physiol Scand 163 (1998) 121-129
5. Davie N., Haleen S.J., Upton P.D., et al. ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cells. Am J Respir Care Med 165 (2002) 398-405
6. Clozel M., Gray G.A., Breu V., Loffler B.M., and Osterwalder R. The endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivo. Biochem Biophys Res Commun 186 (1992) 867-873
7. Belloni A.S., Rossi G.P., Andreis P.G., et al. Endothelin adrenocortical secretagogue effect is mediated by the B receptor in rats. Hypertension 27 (1996) 1153-1159
8. Davenport A.P., O'Reilly G., Molenaar P., et al. Human endothelin receptors characterized using reverse transcriptase-polmerase chain reaction, in situ hybridization, and subtype-selective ligands BQ123 and BQ3020: evidence for expression of ETB receptors in human vascular smooth muscle. J Cardiovasc Pharmacol 22 Suppl. 8 (1993) S22-S25
9. Ogawa Y., Nakao K., Arai H., et al. Molecular cloning of a non-isopeptide-selective human endothelin receptor. Biochem Biophys Res Commun 178 (1991) 225-248
10. Fukuroda T., Kobayashi M., Ozaki S., et al. Endothelin receptors subtypes in human versus rabbit pulmonary arteries. J Appl Physiol 76 (1994) 1976-1982
11. Rubanyi G.M., and Polokoff M.A. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 46 (1994) 325-415
12. Juergens U.R., Christiansen S.C., Stevenson D.D., and Zuraw B.L. Inhibition of monocyte leukotriene B4 production after aspirin desensitization. J Allergy Clin Immunol 96 (1995) 4148-4156
13. Juergens U.R., Engelen T., Stöber M., Racké K., Gillissen A., and Vetter H. Inhibitory activity of 1,8-cineol (eucalyptol) on cytokine production in human mononuclear phagocytes in vitro. Pulm Pharmacol Ther 17 (2004) 281-287
14. Matthiesen S., Bahulayan A., Kempkens S., Fuhrmann R., Stichnote C., Haag S., et al. Muscarinic receptors mediate stimulation of human lung fibroblast proliferation. Am J Respir Cell Mol Biol 35 (2006) 621-627
15. Dingemanse J., and van Giershagen P.L.M. Clinical pharmacology of bosentan, a dual endothelin receptor antagonist. Clin Pharmacokinet 43 15 (2004) 1089-1115
16. Juergens U.R., Jäger F., Darlath W., Stöber M., Vetter H., and Gillissen A. Comparison of in vitro-activity of commonly used topical glucocorticoids on cytokine- and phospholipase inhibition. Eur J Med Res 9 8 (2004) 383-390
17. King J.K., Srivastava K.D., Stefano G.B., Bilfinger T.V., Bahou W.F., and Magazine H.I. Human monocyte adhesion is modulated by endothelin B receptor-coupled nitric oxide release. J Immunol 158 (1997) 880-886
18. Rankin J.A. The contribution of alveolar macrophages to hyperreactive airway disease. J Allergy Clin Immunol 83 (1990) 722-729
19. Jones C.M., Hall E.R., Hester P.J., and WU K.K. Arachidonic acid metabolites produced by platelet-depleted human blood monocytes: a possible role in thrombogenesis. Am J Hematol 31 (1989) 145-152
20. McCarter S.D., Lai P.F., Suen R.S., and Stewart D.J. Regulation of endothelin-1 by angiopoietin-1: implications fir inflammation. Exp Biol Med 231 6 (2006) 985-991
21. Kamoun W.S., Karaa A., Kresge N., Merkel S.M., Korneszczuk K., and Clemens M.G. LPS inhibits endothelin-1-induced endothelial NOS activation in hepatic sinusoidal cells through a negative feedback involving caveolin-1. Hepatology 43 1 (2006) 182-190
22. Wu C.Y., Kaur C., Lu J., Cao Q., Guo C.H., Zhou Y., et al. Transient expression of endothelins in the amoeboid microglial cells in the developing rat brain. Glia 54 6 (2006) 513-525
23. Wahl J.R., Goetsch N.J., Young H.J., Van Maanen R.J., Johnson J.D., Pea A.S., et al. Murine macrophages produce endothelin-1 after microbial stimulation. Exp Biol Med 230 9 (2005) 652-658
24. Finsnes F., Lyberg T., Christensen G., and Skjonsberg O.H. Effect of endothelin antagonism on the production of cytokines in eosinophilic airway inflammation. Am J Physiol Lung Cell Mol Physiol 280 (2001) 659-665
25. Cunningham M.E., Huribal M., Bala R.J., and McMillen M.A. Endothelin-1 and endothelin-4 stimulate monocyte production of cytokines. Crit Care Med 25 6 (1997) 958-964
26. Wilson S.H., Simari R.D., and Lerman A. The effect of endothelin-1 on nuclear factor kappa B in macrophages. Biochem Biophys Res Commun 286 (2001) 968-972
27. McMillen M.A., Huribal M., Cunningham M.E., Kumar R., and Sumpio B.E. Endothelin-1 increases intracellular calcium in human monocytes and causes production of interleukin-6. Am J Crit Care Med 23 (1995) 34-40
28. Keller S., Kara A., Paxian M., Clemens M.G., and Zhang J.X. Inhibition of endothelin-1-mediated up-regulation of iNOS by bosentan ameliorates endoxin-induced liver injury in cirrhosis. Shock 25 3 (2006) 306-313
29. Shi Y., Lau C., and Cupples W.A. Comp interactive modulation of renal myogenic autoregulation by nitric oxide and endothelin acting through ET-B receptors. Am J Physiol Regul Integr Physiol 292 1 (2007) R354-R361
30. Bagnall A.J., Kelland N.F., Gulliver-Sloan F., Davenport A.P., Gray G.A., Yanagisawa M., et al. Deletion of endothelial B receptors does not affect blood pressure or sensitivity to salt. Hypertension 48 2 (2006) 286-293
31. Kuklin V.N., Kirov M.Y., Evgenov O.V., Sovershaev M.A., Sjoberg J., Kirova S.S., et al. Novel endothelin receptor antagonist attenuates endotoxin-induced lung injury in sheep. Crit Care Med 32 3 (2004) 766-773
32. Wort S.J., Woods M., Warner T.D., Evans T.W., and Mitchell J.A. Cyclooxygenase-2 acts as an endogenous brake on endothelin-1 release by human pulmonary artery smooth muscle cells: implications for pulmonary hypertension. Mol Pharmacol 62 (2002) 1147-1153
33. Fabricio As., Veiga F.H., Cristofolrtti R., Navarr P., and Souza G.E. The effects of selective and nonselective cyclooxygenase inhibitors on endothelin-1-induced fever in rats. Am J Physiol Regul Integr Comp Physiol 288 3 (2005) R671-R677
34. 2 inhibit ET-1 secretion from endothelial cells by stimulating particulate guanylate cyclase. Am J Physiol 270 4 Pt 2 (1996) H1342-H1349
35. Muller D.N., Mervaala E.M.V., Schmidt F., Park J.K., Dechend R., Genersch E., et al. Effect of bosentane on NF-κB inflammation, and tissue factor in angiotensin II-induced end-organ damage. Hypertension 36 (2000) 282-290
36. Opitz C.F., and Ewert R. Dual ET(A)/ET(B) vs. selective ET(A) endothelin receptor antagonism in patients with pulmonary hypertension. Eur J Clin Invest 36 Suppl. 3 (2006) 1-9
37. Van de Water F.M., Russel F.G., and Masereeuw R. Regulation and expression of endothelin-1 (ET-1) and ET-receptors in rat epithelial cells of renal and intestinal origin. Pharmacol Res 54 6 (2006) 429-435
38. B receptor expression in cerebral arteries. BMC Pharmacol 28 (2006) 6:13
39. Peled M., Shaish A., Frishman L., Cohen H., Tal R., and Harats D. Endothelin B receptor antagonist increases preproendothelin-1 transcription in bovine aortic endothelial cells and in vivo. J Cardiovasc Pharmacol 47 5 (2006) 668-672
40. Ivy D., McMurtry I.F., Yanagisawa M., Gariepy C.E., Le Cras T.D., Gepp S.A., et al. Endothelin B receptor deficiency potentiates ET-1 and hypoxic pulmonary vasoconstriction. Am J Physiol Lung Cell Mol Physiol 280 5 (2001) L1040-L1048